To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19
Clinical trial NCT05813587 · COMPLETED
Trial details
- NCT number
- NCT05813587
- Sponsor
- Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2023-09-14
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.